Frontiers in Pharmacology | Gastrointestinal and Hepatic Pharmacology

Systematic Review

Published on 27 May 2025

Novel insights from meta-analysis: the efficacy of ginsenosides in non-alcoholic fatty liver disease

in Gastrointestinal and Hepatic Pharmacology

Liyuan Hao
Qing Peng
Shenghao Li
Xiaoyu Hu
Huimin Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1564852

255 views

Systematic Review

Published on 27 May 2025

Efficacy of interventions with live combined Bacillus subtilis and Enterococcus faecium enteric-coated capsules in metabolic associated fatty liver disease patients: a meta-analysis of randomized controlled trials

in Gastrointestinal and Hepatic Pharmacology

Yutong Wu
Hao Wu
Hang Yi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1610426

286 views

Original Research

Accepted on 23 May 2025

Real-World Data of Azvudine-induced Hepatotoxicity Among Hospitalized COVID-19 Patients in China: A Retrospective Case-control Study

in Gastrointestinal and Hepatic Pharmacology

Yuanguo Xiong
Hao Xin
Cai Shi
Xianxi Guo
Ying Chen
Caifei Huang
Fuwang Ma
Ge Yang
Jian Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558054

530 views

Editorial

Accepted on 23 May 2025

Editorial: Microbiome: The Modulator of Human Health

in Gastrointestinal and Hepatic Pharmacology

Ji Youn Yoo
Moumita Dutta

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1625412

398 views

Original Research

Accepted on 23 May 2025

Role of gut microbiota in bempedoic acid against hyperlipidemia: A new candidate target for bempedoic acid on the therapeutic regulation

in Gastrointestinal and Hepatic Pharmacology

Wei-jian Zhang
Jian Wang
Ouyang Ziqi
Sen-Rong Luo
Chen Zhikai
Yuan-Kang He
Mu-Jin Luo
Xuxing Liao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1584273

392 views

Review

Published on 23 May 2025

A potential herbal component for the future treatment of fatty liver disease: Geniposide from gardenia

in Gastrointestinal and Hepatic Pharmacology

Qinyao Zhang
Ziyan Li
Lina Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1610676

377 views

Study Protocol

Accepted on 22 May 2025

Efficacy and Safety of Local Glucocorticoids for the Treatment of Acute Radiation-Induced Intestinal Injury: Protocol of a Multicenter Randomized Controlled

in Gastrointestinal and Hepatic Pharmacology

Qianqian Li
Xiaofeng Liu
Lichun Shao
Xiaohua Bao
Cheng Bai
Junchen Ge
Dongshuai Su
Wenda Xu
Ran Jiang
Zhenbin Mu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529977

104 views

Review

Published on 22 May 2025

Pharmacological potential of endocannabinoid and endocannabinoid-like compounds in protecting intestinal structure and metabolism under high-fat conditions

in Gastrointestinal and Hepatic Pharmacology

Francesco Vari
Ilaria Serra
Marzia Friuli
Viviana Cavallo
Nicola Gammaldi
Daniele Vergara
Michel Salzet
Anna M. Giudetti

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1567543

540 views

Original Research

Published on 22 May 2025

Dynamic relationship between gut microbiota and post-necrotizing pancreatitis: insights from a multi-stage 16S rRNA sequencing study

in Gastrointestinal and Hepatic Pharmacology

Jiongdi Lu
Zhe Wang
Feng Cao
Jia Li
Guofeng Ji
Fei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1577558

289 views

Review

Published on 21 May 2025

Vitamin B5 and vitamin U review: justification of combined use for the treatment of mucosa-associated gastrointestinal pathologies

in Gastrointestinal and Hepatic Pharmacology

Valentin P. Shichkin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1587627

580 views

Review

Published on 19 May 2025

Insights into the gut-liver axis: mechanisms and emerging therapies in hepatocellular carcinoma

in Gastrointestinal and Hepatic Pharmacology

Yongjian Hu
Mingming Gao
Jiajin Chenghuang
Rui Bao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1595853

468 views

Original Research

Published on 16 May 2025

2-Dodecyl-6-methoxycyclohexa-2,5-dien-1,4-dione alleviates liver fibrosis and improves intestinal flora and bile acid metabolism

in Gastrointestinal and Hepatic Pharmacology

Yongfei He
Thi Thai Hoa Pham
Junming Xu
Shengjie Hong
Jicai Wang
Hang Zhai
Qiang Tao
Ruixi Li
Guangquan Zhang
Xianjie Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1581138

407 views

Original Research

Published on 15 May 2025

Pan-cancer profiling of FZD2 as a prognostic biomarker: integrative multi-omics analysis with experimental validation and functional characterization in gastric cancer

in Gastrointestinal and Hepatic Pharmacology

Sijiang Zhou
Da Li
Chao Quan
Zhu Yu
Yue Feng
Shengyu Wang
Yong Li
Tongtong Qi
Junqiang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1534974

418 views

Systematic Review

Accepted on 14 May 2025

A systematic review and meta-analysis of efruxifermin's efficacy in improving liver fibrosis in patients with NASH/MASH

in Gastrointestinal and Hepatic Pharmacology

Shuzhai Li
Wangyuan Zou
Yingying Zhou
Wenjie Li
Wei Liao
Tao Li
Zhiming Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1594091

210 views

Original Research

Published on 13 May 2025

First-line treatment of hepatocellular carcinoma: a propensity-matched analysis of tyrosine kinase inhibitors combined with TACE, with or without PD-1 inhibitors

in Gastrointestinal and Hepatic Pharmacology

Yanjun Shen
Yawen Xu
Ying Teng
Xiaoyan Ding
Jinglong Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533471

436 views

Mini Review

Published on 12 May 2025

Effect of Diquat on gut health: molecular mechanisms, toxic effects, and protective strategies

in Gastrointestinal and Hepatic Pharmacology

Cheng He
Guorong Cai
Yingmao Jia
Rong Jiang
Xiaolan Wei
Ning Tao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1562182

443 views